Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

1280px-epi-pen_1

Drugstore chain CVS offers EpiPen generic for 600% cheaper

January 12, 2017 Medical Communications, Sales and Marketing CVS, Mylan, epipen

The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …
News
biocon_office

Mylan and Biocon apply to FDA for biosimilar approval

January 12, 2017 Sales and Marketing Biocon, FDA, Mylan, biosimilar, trastuzumab

Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …
News
shire_image_4

Shire fined $350 million in largest-ever bribery case of its kind

January 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …
News

MPS extends its range of child resistant packaging

January 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …
News
Press release
merck_and_co

MSD looks to jump the gun with combination immunotherapy application

January 11, 2017 Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …
News

SHL brings innovation to Pharmapack Europe 2017

January 10, 2017 Manufacturing and Production, Research and Development, Sales and Marketing auto injector, connectivity, delivery devices, smart packaging

As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …
News
Press release
fda2outsideweb

Egalet gains FDA approval for difficult to abuse painkiller

January 10, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Arymo ER, Egalet Corp, FDA

Egalet has gained FDA approval for Arymo ER, a long-acting opioid painkiller that is made to be difficult to breakdown. …
News
valeant_web

Valeant to sell cancer business to Sanpower for $820m

January 10, 2017 Manufacturing and Production, Sales and Marketing Dendreon, Sanpower, Valeant

Valeant Pharmaceuticals has announced it is to sell its cancer business Dendreon to Chinese firm Sanpower in a deal worth …
News
takeda_tokyo_hq

Takeda to acquire Ariad in $5.2 billion deal

January 9, 2017 Manufacturing and Production, Sales and Marketing Ariad, Takeda

Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …
News
abbottweb_2

Abbott completes $25 billion deal for St. Jude

January 9, 2017 Sales and Marketing Abbott, St. Jude

It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …
News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten most popular articles of 2016

January 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …
Feature
amgen_hq

Amgen and Immatics enter $1bn immuno-oncology partnership

January 9, 2017 Research and Development, Sales and Marketing Amgen, immatics, immunotherapy

Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …
News
handshake-1910702_960_720

Merrimack sells off drug for $1 billion and cuts workforce by 80%

January 9, 2017 Sales and Marketing Onivyde, ipsen, merrimack

Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …
News
roche

Roche’s Tecentriq scores another bladder cancer Priority Review

January 9, 2017 Sales and Marketing Roche, bladder cancer, tecentriq

Roche has announced that its immunotherapy drug Tecenetriq (atezolizumab) has been awarded Priority Review by the FDA for the treatment …
News
erik_digman_wiklund

Targovax promotes new CFO

January 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targovax

Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …
Appointment
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026